GPC to Build $120M US Genomics Facility for Altana | GenomeWeb

NEW YORK, Nov. 8 – GPC Biotech of Munich said Thursday it had agreed to build a $120 million genomics research center for German chemicals and pharmaceuticals company Altana, which will use the new facility to advance two of its drug discovery programs.

Under the terms of the three agreements that make up the five-and-a-half-year deal, Altana has committed $120 million to the center, which it will own, over the duration of the alliance. The new center will be based in Waltham, Mass.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."